Global Life Science Analytics Market Assessment, By Type [Descriptive Analytics, Predictive Analytics, Prescriptive Analytics], By Component [Software, Services], By Delivery [On-Premises Model, On-Demand Model], By Application [Research and Development, Regulatory Compliance, Supply Chain Optimization, Clinical Trials, Pharmacovigilance, Sales and Marketing, Others], By End-user [Pharmaceutical, Biotechnology, Medical Device, Others], By Region, By Opportunities and Forecast, 2017-2031F

Life Science Analytics Market is projected to witness a CAGR of 8.12% during the forecast period 2024-2031F, growing from USD 17.66 billion in 2023 to USD 32.98 billion in 2031F.

Life Science Analytics Market Size, Share, Trends and Forecast 2031

Global life science analytics market&nbsp;is projected to witness a&nbsp;CAGR of 8.12%&nbsp;during the forecast period 2024-2031F, growing from&nbsp;USD 17.66 billion&nbsp;in 2023 to&nbsp;USD 32.98 billion&nbsp;in 2031F. The life science analytics market is a rapidly growing market due to factors such as increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes and cancer, increasing application of artificial intelligence and machine learning in life sciences and rising adoption of advanced analytics solutions in pharmaceuticals and clinical trials.
Any analytical tool used by pharmaceutical companies, clinical research organizations, and a host of other departments, such as supply chain, marketing, pharmacovigilance, and research, may be categorized as a life science analytics tool. It is a clinical data analysis technique that offers forecasting tools for better patient treatment and management.&nbsp;Real-world statistical&nbsp;data analysis&nbsp;skills have&nbsp;become critical in an ever-evolving environment that seeks innovation. Life science businesses are increasingly using data analytics to sort through social media data, CRO, and EHR data in order to better guide their product choices, enhance their current offerings, and improve patient outcomes. Through the use of platforms like Qlik, businesses may investigate large amounts of data and obtain market insights that can be used to R&amp;D, clinical, GMA, and commercial operations. According to a recent Deloitte poll, 91% of life sciences businesses intend to invest in R&amp;D innovation in 2023, and over half of them are optimistic about the industry's prospects for that year. However, the success of the present high-risk, high-cost R&amp;D framework still has to overcome major financial challenges. To overcome these obstacles and prosper in the post-pandemic environment, life sciences research and development (R&amp;D) companies need to give top priority to accelerating digital transformation projects, strategic changes, and commercial restructuring.
<h2 style="text-align: justify;">Increasing Application of Artificial Intelligence and Machine Learning in Life Sciences</h2>
Most organizations in life sciences and healthcare have only scratched the surface of AI and ML&rsquo;s potential. AI and ML are primarily being used to automate repetitive tasks and standard business processes. However, AI is now widely recognized as a strategic business issue in this area and is actively being discussed at the board and C-suite levels. By combining AI technology with the fields of medicine and science, organizations are looking for opportunities to transform some of their most critical processes and achieve sustainable competitive advantage through AI. AI is predicted to have a revolutionary effect on biopharma research and development (R&amp;D) within the next three to five years, especially in the area of drug discovery. Life sciences businesses will follow&nbsp;proof-of-concept and pilot programs for AI in many other areas of the value chain in the interim.
As per a report published by Philips&rsquo;s Future Health Index report for 2024, 2,800 respondents from 14 different countries indicated that 85% of them invest in technology or plan to do so in the next three years.
<h2 style="text-align: justify;">Rising Adoption of Advanced Analytics Solutions in Pharmaceuticals, Medical Devices and Clinical Trials</h2>
Healthcare leaders see a wide range of opportunities to improve patient care by bringing data from disparate sources together in a meaningful way. Healthcare professionals believe data-driven insights could help optimize treatment plans and care pathways, identify evidence-based practices, and reduce waiting lists for diagnostic and elective procedures. However, to deliver on these possibilities, healthcare leaders recognize they first need to get the foundations right. The foundation of seamless data integration can be done by improving the accuracy of patient data, enhancing interoperability among different platforms and healthcare settings, and strengthening data security and privacy. Healthcare executives see several chances to enhance patient care by integrating data from various sources. Healthcare practitioners think data-driven insights might assist in finding evidence-based treatments, streamline treatment plans and care pathways, and shorten waiting lists for elective and diagnostic procedures. Healthcare executives understand that, in order to realize these opportunities fully, they must first lay the necessary groundwork. Improving patient data accuracy, boosting platform and healthcare setting interoperability, and fortifying data security and privacy are the cornerstones of a smooth data integration process.
In 2024, Yotta Data Services announced a partnership with Partex NV to improve healthcare services in drug discovery and patient care. The partnership will leverage Yotta's Shakti-Cloud platform, backed by Nvidia H100 GPU processing infrastructure, to enable Partex's AI-driven healthcare solutions. The collaboration intends to create AI-based solutions that will improve healthcare services' efficacy and efficiency, especially in the areas of patient care and drug&nbsp;development.&nbsp;
<h2 style="text-align: justify;">Predictive Analytics is Expected to Register Fast Growth in the Forecast Period</h2>
Predictive analytics may improve healthcare by assisting in clinical decision-making, providing direction for population health management, and promoting value-based treatment. In the healthcare industry, predictive analytics is essential in&nbsp;enhancing patient outcomes and the delivery of treatment. This kind of analytics enables health organizations to predict future outcomes from an operational and clinical standpoint by utilizing past data. Healthcare organizations seeking value-based care may find this capacity especially helpful, as it can assist stakeholders in identifying areas where their present strategies may be insufficient and working toward changing them.
For instance, mPulse Mobile, Inc reported strong Q1 2024 growth and launched a new predictive analytics and engagement solution in 2024. In addition, mPulse announced the opening of a new category in the digital health ecosystem with the introduction of its omnichannel engagement and integrated predictive analytics product capabilities. Growth at mPulse was driven by increased automation and efficiency in its business areas for health portals, predictive analytics, and omnichannel interaction.
<a href="https://www.marketsandata.com/industry-reports/life-science-analytics-market/sample-request">Download Free Sample Report</a>
<h2 style="text-align: justify;">North America Dominates the Global Life Science Analytics Market</h2>
In the life sciences analytics&nbsp;sector, North America serves as the&nbsp;epicenter for innovation and technical developments. Numerous well-known biotechnology, pharmaceutical, and medical device companies&nbsp;are based in the area, and they extensively engage in data analytics to maintain regulatory compliance, boost sales and marketing initiatives, improve clinical trial quality, and increase productivity in research and development. Leading research institutes and a strong healthcare system are two other factors that make North America&nbsp;a leader in life science analytics. Adoption of advanced analytics solutions is also required in North American countries due to their complex regulatory framework and well-established data management processes.
In 2024, OpenAI Inc. announced its partnership with Color Health, Inc. to apply its AI models to cancer detection and treatment, hence expanding the application of AI in healthcare. Using OpenAI's GPT-4o model, Color Health, a startup that was established in 2013 as a genetic testing firm, developed an AI assistant or "copilot" in 2024. The copilot assists physicians in developing pretreatment programs for patients with cancer diagnoses as well as strategies for cancer screening.
Future Market Scenario (2024-2031F)
The value of data analytics in fostering innovation and growth is now well-acknowledged in the life science sector. With applications ranging from predictive modeling to personalized medicine, this technology has the potential to completely change the way the world sees healthcare. Artificial intelligence is developing at a fast pace; it transforms the commercial world and increases our trust in utilizing automation, robots, and machine learning. Unlike traditional&nbsp;approaches, modern machine learning and artificial intelligence systems can handle vast&nbsp;data sets. It improves the ability to foresee and manage, which, in the end, means saving lives in the healthcare industry. Data analytics appears to have a bright and exciting future in the life science sector. Given the industry's ongoing adoption of AI technology and data-driven methodologies, it is essential to discuss the ethical implications and issues associated with these developments. In order to improve patient outcomes, streamline operations, and spur innovation, the life science industry can responsibly and effectively harness the power of data analytics by investing in data privacy and security, addressing biases, fostering transparency, encouraging collaboration, and developing a skilled workforce.
Report Scope
&ldquo;Life Science Analytics&nbsp;Market Assessment, Opportunities, and Forecast, 2017-2031F&rdquo;,&nbsp;is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global life science analytics market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
<table>
<tbody>
<tr>
<td width="301">
Report Attribute
</td>
<td width="301">
Details
</td>
</tr>
<tr>
<td width="301">
Base Year of the Analysis
</td>
<td width="301">
2023
</td>
</tr>
<tr>
<td width="301">
Historical Period
</td>
<td width="301">
2017-2022
</td>
</tr>
<tr>
<td width="301">
Forecast Period
</td>
<td width="301">
2024-2031F
</td>
</tr>
<tr>
<td width="301">
Projected Growth Rate
</td>
<td width="301">
CAGR of 8.12% between 2024 and 2031F
</td>
</tr>
<tr>
<td width="301">
Revenue Forecast in 2031
</td>
<td width="301">
USD 32.98 billion
</td>
</tr>
<tr>
<td width="301">
Segments Covered
</td>
<td width="301">
Type, Component, Delivery, Application, End-user
</td>
</tr>
<tr>
<td width="301">
Regions Covered
</td>
<td width="301">
North America, Europe, South America, Asia-Pacific, Middle East and Africa
</td>
</tr>
<tr>
<td width="301">
Key Companies Profile
</td>
<td width="301">
Oracle Systems Corporation, IBM Corporation, Accenture Plc, IQVIA Holdings Inc, Cognizant Technology Solutions Corporation, Wipro Enterprises Limited, Allscripts Healthcare Solutions Inc, Optum Inc, Microsoft Corporation and SAS Institute Inc
</td>
</tr>
<tr>
<td width="301">
Customization Scope
</td>
<td width="301">
15% free report customization with purchase
</td>
</tr>
<tr>
<td width="301">
Pricing and Purchase Options
</td>
<td width="301">
Avail the customized purchase options to fulfill your precise research needs
</td>
</tr>
<tr>
<td width="301">
Delivery Format
</td>
<td width="301">
PDF and Excel through email (subject to the license purchased)
</td>
</tr>
</tbody>
</table>
In this report, the&nbsp;global&nbsp;life science analytics market&nbsp;has been segmented into the following categories:&nbsp;
<ul style="text-align: justify;">
<li>By Type
<ul>
<li>Descriptive Analytics</li>
<li>Predictive Analytics</li>
<li>Prescriptive Analytics</li>
</ul>
</li>
<li>By Component
<ul>
<li>Software</li>
<li>Services</li>
</ul>
</li>
<li>By Delivery
<ul>
<li>On-Premises Model</li>
<li>On-Demand Model</li>
</ul>
</li>
<li>By Application
<ul>
<li>Research and Development</li>
<li>Regulatory Compliance</li>
<li>Supply Chain Optimization</li>
<li>Clinical Trials</li>
<li>Pharmacovigilance</li>
<li>Sales and Marketing</li>
<li>Others</li>
</ul>
</li>
<li>By End-user
<ul>
<li>Pharmaceutical</li>
<li>Biotechnology</li>
<li>Medical Device</li>
<li>Others</li>
</ul>
</li>
<li>By Region
<ul>
<li>North America</li>
<li>Europe</li>
<li>South America</li>
<li>Asia-Pacific</li>
<li>Middle East and Africa&nbsp;</li>
</ul>
</li>
</ul>
Key Players Landscape and Outlook
Several medical device companies like Oracle Systems Corporation, IBM Corporation, Accenture Plc, IQVIA Holdings Inc, Cognizant Technology Solutions Corporation, Wipro Enterprises Limited, Allscripts Healthcare Solutions Inc, Optum Inc, Microsoft Corporation and SAS Institute Inc are flourishing in the global life science analytics market by planning and adopting new strategies. They are complying with new strategic initiatives for AI and ML technologies to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.
In June 2024, Simplify Healthcare Technology acquired&nbsp;Virtical.ai in order to expedite the integration of artificial intelligence. The consumer bases of both organizations are going to benefit greatly from the acquisition. The advanced&nbsp;AI platform from Virtical.ai and the well-established cloud-based platform from Simplify Healthcare, Simplify Health Cloud, will combine to deliver an&nbsp;effective&nbsp;tool&nbsp;that will enable payers to achieve new heights of creativity, efficiency, and growth enablers.
Key Players Operating in the Global Life Science Analytics Market are:
<ul style="text-align: justify;">
<li>Oracle Systems Corporation</li>
<li>IBM Corporation</li>
<li>Accenture Plc</li>
<li>IQVIA Holdings Inc</li>
<li>Cognizant Technology Solutions Corporation</li>
<li>Wipro Enterprises Limited</li>
<li>Allscripts Healthcare Solutions Inc</li>
<li>Optum Inc</li>
<li>Microsoft Corporation</li>
<li>SAS Institute Inc.</li>
</ul>
Markets and Data&rsquo;s reports answer the following questions:
<ul style="text-align: justify;">
<li>What is the current and future market size of the product/service in question globally or specific to different countries?</li>
<li>How are the markets divided into different product/service segments and the market size and growth of each segment?</li>
<li>What is the market potential of different product segments and their investment case?</li>
<li>How are the markets predicted to develop in the future and what factors will drive or inhibit growth?</li>
<li>What is the business environment and regulatory landscape specific to the product/service?</li>
</ul>
If you can't find what you're searching for or have any custom requirements for the global life science analytics market, you may approach our team at&nbsp;<a href="mailto:info@marketsandata.com">info@marketsandata.com</a>.

Global Life Science Analytics Market Assessment, Opportunities and Forecast, 2017-2031F

Healthcare leaders see a wide range of opportunities to improve patient care by meaningfully bringing data from disparate sources together. Healthcare professionals believe data-driven insights could help optimize treatment plans and care pathways, identify evidence-based practices, and reduce waiting lists for diagnostic and elective procedures.

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics